School of Medicine
Showing 401-500 of 743 Results
-
Stuart Kim
Professor of Developmental Biology, Emeritus
Current Research and Scholarly InterestsMechanisms of Aging in C. elegans and humans.
-
Sun Kim, M.D. M.S.
Associate Professor of Medicine (Endocrinology)
Current Research and Scholarly InterestsWe are interested in studying the pathophysiological processes that contribute to glucose intolerance and type 2 diabetes mellitus. My current research focuses on characterizing pancreatic beta-cell function in populations with significant insulin resistance and vulnerability to developing diabetes: individuals with schizophrenia, morbid obesity, and history of gestational diabetes.
-
Sunhee S. Kim, MD
Clinical Assistant Professor, Surgery - General Surgery
BioDr. Sunhee Serenity Kim is a board-certified, fellowship-trained general surgeon at Stanford Health Care and clinical assistant professor in the Department of Surgery, Division of General Surgery at Stanford University School of Medicine. She is also the director of emergency general surgery and clinical medical director of the general surgery outpatient clinic at Stanford Health Care Tri-Valley.
Dr. Kim specializes in acute care surgery, applying minimally invasive surgical approaches such as robotic surgery. Dr. Kim treats a broad range of diseases, including gallbladder disease, diverticular disease, ventral and inguinal hernias, and benign breast disease. She has particular interest in enteroatmospheric and enterocutaneous fistula treatment.
Dr. Kim’s research interests have included cytokinesis, rare genetic mutations in blood cancers, and surgical treatment outcomes in people with pancreatic cancer. Most recently, she has performed clinical research with trauma and emergency general surgery patients.
Dr. Kim has published her research in peer-reviewed journals, including The American Journal of Surgical Pathology, Journal of the National Cancer Institute, Nature Communications, and Proceedings of the National Academy of Sciences. She has also presented to her peers at national meetings, including annual meetings of the Society of Surgical Oncology, American Society of Clinical Oncology, and Association for Academy Surgery.
Dr. Kim is a member of the American College of Surgeons (ACS). -
Yeuen Kim
Clinical Associate Professor, Medicine - Vaden Health Center
BioYeuen Kim MD MAS is an internal medicine physician with expertise in population health, medical humanities educational interventions, and working with vulnerable populations in urban settings. She trained at Brown University's Program in Liberal Medical Education and completed residency/chief residency at the Santa Clara Valley Medical Center in San Jose, CA. She has worked with vulnerable populations in ambulatory and mobile settings as a primary care attending and medical outreach physician, as well as completing a Masters' and fellowship in clinical research at UCSF's Department of Biostatistics and Epidemiology & SFGH DGIM, where she evaluated electronic referrals to subspecialty clinics from safety settings (Kim, Chen et al, JGIM 2009.) She worked with the SF and Santa Clara County public health departments to help reduce mortality and improve COVID19 and mpox mitigation, especially at congregate residential facilities through better ventilation, public-private collaboration, and addressing determinants of health for essential workers. Since 2013, she has facilitated art gallery-based workshops for physicians and learners to improve observation and communication skills. She co-leads narrative medicine and oncology workshops for students, residents (Edwards, Kim et al, BMJ Educ 2022) and faculty as a clinical associate professor in Primary care and population health.
-
Yo Sup Kim
Clinical Scholar, Radiology
Fellow in Rad/Musculoskeletal ImagingBioI completed both my diagnostic radiology residency at Indiana University School of Medicine and my MBA at the Kelley School of Business Indiana University on June 2025. I am currently pursuing my fellowship in Musculoskeletal Radiology at Stanford. My healthcare-related interests and research primarily involve applying real world business practices in radiology for optimal efficiency and maximizing value (e.g. using linear regression analysis to finding variables that impact volume of CT studies at the ER). Outside of healthcare, I have entrepreneurial interests particularly in the area of venture capitalism for tech and service companies. Prior to medical school, I ran my family's floral bouquet company in California.
-
Yong Yean Kim
Assistant Professor of Pediatrics ( Hematology & Oncology)
BioOur lab is interested in translational science to bring new therapies to clinical trials. In particular, we are interested in pediatric sarcomas which have not had advancement in clinical treatment for decades. Current projects in the lab focus on understanding of the biology of fusion transcription factor PAX3::FOXO1 which is the driver mutation in fusion positive rhabdomyosarcoma. PAX3::FOXO1 is a powerful oncogenic transcription factor which rewires the transcriptional organization to lock the cancer cell in the proliferative state. Since transcription factors including PAX3::FOXO1 are difficult to target using small molecules, we aim to understand how PAX3::FOXO1 is regulated and targeting the regulators of PAX3::FOXO1. By understanding and targeting the regulation of PAX3::FOXO1, we hope to bring new therapies for fusion positive rhabdomyosarcoma. Additionally, these regulatory mechanisms may also be active in other transcription driven cancers such as the EWSR1::FLI1 driven Ewings Sarcoma.
Our lab is also interested in exploring the epigenetic landscape of pediatric solid tumors and trying to understand how dysregulation in the epigenome drives oncogenesis. We utilize various CRISPR mediated genetic techniques to interrogate the regulators of epigenome focusing on the histone lysine demethylases (KDMs). KDMs are an understudied group of epigenetic regulators which can be targeted for therapeutic effect. We explore the role of KDMs in pediatric solid tumors and hope to identify potential targets for drug development. -
Youn H Kim, MD
The Joanne and Peter Haas, Jr., Professor for Cutaneous Lymphoma Research and Professor, by courtesy, of Medicine (Oncology)
Current Research and Scholarly InterestsClinical research in cutaneous lymphomas, especially, mycosis fungoides; studies of prognostic factors, long-term survival results, and effects of therapies. Collaborative research with Departments of Pathology and Oncology in basic mechanisms of cutaneous lymphomas. Clinical trials of new investigative therapies for various dermatologic conditions or clinical trials of known therapies for new indications.
-
Mia Kimura
Events Manager, Chief of Staff
BioMia Kimura is an Events Manager in the Strategy and Communications unit of the Office of the Dean of the School of Medicine.
-
Benyam Z. Kinde, MD, PhD
Assistant Professor of Ophthalmology
BioDr. Kinde is a board-certified, fellowship-trained ophthalmologist and ophthalmic plastic and reconstructive surgeon at Stanford Health Care Byers Eye Institute. He is also an assistant professor in the Department of Ophthalmology at Stanford University School of Medicine. Dr. Kinde completed the American Society of Ophthalmic and Plastic Reconstructive Surgery (ASOPRS) fellowship in ophthalmic plastic surgery through the Bascom Palmer Eye Institute at the University of Miami.
Dr. Kinde diagnoses and treats a wide range of conditions related to the eyelid and other eye structures, including facial nerve palsy, skin cancer, and thyroid eye disease. He also provides care for patients who wish to enhance their appearance through surgical and nonsurgical interventions. Dr. Kinde offers many types of treatments, including cosmetic surgery, eyelid surgery (including upper and lower eyelid blepharoplasty and ptosis surgery), reconstructive surgery, tear duct (lacrimal) surgery, and orbital surgery.
Dr. Kinde is a physician-scientist whose research interests focus on developing new tools to promote survival of retinal ganglion cells after optic nerve injury. He has investigated how modulating the DNA damage response in mouse models of traumatic optic neuropathy (symptoms of nerve damage) may promote and improve optic nerve function after injury. His previous work focused on increasing the resilience of neurons (messaging nerve cells) in mouse models of glaucoma and in humans with glaucoma. He completed his MD and PhD in neuroscience at Harvard Medical School, where his thesis work revealed a new understanding of Rett syndrome, a rare genetic disorder that affects body movement.
Dr. Kinde has published in many peer-reviewed journals, including Nature, Science, Cell, Ophthalmology, and Facial Plastic Surgery & Aesthetic Medicine. He has presented to his peers at international and national meetings, including the Association for Research in Vision and Ophthalmology, American Society of Ophthalmic Plastic and Reconstructive Surgery, and Inter-American Course in Clinical Ophthalmology. -
Christian Kindermann
Research Engineer, Computational Medicine
Current Role at StanfordI am a research engineer specializing in semantic technologies (ontologies and knowledge graphs). My work focuses on helping life-science practitioners and researchers manage their data.
-
Abby C. King
David and Susan Heckerman Professor and Professor of Epidemiology & Population Health and of Medicine (Stanford Prevention Research Center)
Current Research and Scholarly InterestsMy interests include applications of behavioral theory and social ecological approaches to achieve large scale changes impacting chronic disease prevention and control; expanding the reach and translation of evidence-based interventions through state-of-the-art technologies; exploring social and physical environmental influences on health; applying community participatory research perspectives to address health disparities; and policy-level approaches to health promotion/disease prevention.
-
Roy King
Associate Professor of Psychiatry and Behavioral Sciences, Emeritus
Current Research and Scholarly InterestsCurrent research centers on the use of human genetic haploid systems, e.g. the Y chromosome, to understand the prehistory of human migrations particularly since the Holocene. This work includes investigating correlations with human symbolic material culture, focusing on the visual artistic realm. Also being explored are the issues and ethical implications of the social construction of race and ethnicity vis a vis the enhanced capacity to differentiate populations using genotypes.
-
David Kingsley
Rudy J. and Daphne Donohue Munzer Professor in the School of Medicine
Current Research and Scholarly InterestsWe use mice, stickleback fish, and humans to study the molecular basis of evolution and common diseases. By combining genetics and genomics, we have identified key DNA changes that control bone formation, limb patterning, hair color, brain evolution, and susceptibility to arthritis, schizophrenia, and bipolar disorder. We find that the same genetic mechanisms are often used repeatedly in nature, providing new insights into the origin of key traits in many different species, including ourselves.
-
Lucas Kipp
Clinical Associate Professor, Adult Neurology
BioDr. Kipp specializes in the diagnosis and treatment of neuroimmunological disorders, particularly demyelinating conditions such as multiple sclerosis and neuromyelitis optica. He is interested in translational research connecting expert MS clinicians, world-renown immunology laboratories, and advanced neuroimaging techniques to identify biomarkers of disease and treatment response.
-
Alaina Kipps
Clinical Professor, Pediatrics - Cardiology
BioDr. Kipps grew up in Santa Cruz, California and completed her medical degree at Harvard Medical School in 2003. After general pediatrics residency at Stanford, she completed pediatric cardiology fellowship at Boston Children’s Hospital from 2006 to 2009. After three years on faculty with University of California, San Francisco she was recruited back to Stanford in 2012 to become the medical director for acute care cardiology (2013-2021). Since 2021 she has focused on QI for the ACCU and heart center, and has served as the ACCU local improvement team medical director since 2013. In 2014 she co-founded the Pediatric Acute Care Cardiology Collaborative (PAC³) with Nicolas Madsen and co-directed this since inception to spring 2026. PAC³ has 50 participating centers, a registry since 2019 with >150,000 encounters, and is the academic society for the ACCU subspecialty. Her academic focus is in clinical effectiveness and quality improvement science, and she completed her Masters of Science in Epidemiology at Harvard School of Public Health in 2016. Her other significant interest is in teaching, mentorship, and coaching. She is the co-director of the Pediatric residency program scholarly concentration in Quality Improvement, co-leads the Pediatric department peer scholar community (in QI), and has served as a residency coach since 2020.
-
Amanda Kirane, MD, PhD, FACS, FSSO
Associate Professor of Surgery (General Surgery)
BioDr. Kirane is a fellowship-trained, board-certified specialist in complex general surgical oncology. She is an Assistant Professor in the Department of Surgery, Section of Surgical Oncology, at Stanford University School of Medicine. Dr. Kirane serves as Director of Cutaneous Surgical Oncology at the Stanford Cancer Center and her clinical practice focuses on the diagnosis and treatment of melanoma and other skin cancers. She partners closely with patients and families to provide the most effective treatment approach possible. For each patient, she tailors an evidence-based, personalized care plan that is innovative, comprehensive, and compassionate.
Dr. Kirane is Principal Investigator of multiple studies in melanoma and mechanisms of resistance to immunotherapy, with focus on myeloid biology. Her current interests include immune response and novel therapies in melanoma, predictive modeling of patient responses using organoid technology, and translational biomarker development. She has led research into immune therapy for earlier stage melanoma using regionally directed therapy to augment immune response in melanoma and trials in surgical care in melanoma.
The National Institutes of Health, American Society of Clinical Oncology, the Melanoma Research Alliance, and others have funded her research. She has co-authored articles on her discoveries in the Journal of Clinical Investigation, Nature Communications, Nature Genetics, Cancer Research, Journal of Surgical Oncology, Annals of Surgery, Annals of Surgical Oncology, and elsewhere. Topics include intratumoral therapy, biomarker development, macrophage biology in melanoma and immunotheraputic resistance, and patient-derived organoid modeling. Dr. Kirane has presented updates on the management of melanoma and other cancers to her peers at meetings of the American College of Surgeons, Society of Surgical Oncology, and Society for Immunotherapy in Cancer.
Dr. Kirane has earned awards for her achievements in clinical care, research, and scholarship. The Society for Immunotherapy of Cancer, Society of Surgical Oncology, Memorial Sloan Kettering Cancer Center, and other prestigious organizations have honored her work. She is a fellow of the American College of Surgeons (FACS) and Society of Surgical Oncology (FSSO). She is a member of the Society for Immunotherapy of Cancer, American Association of Cancer Research, Society for Melanoma Research, Connective Tissue Oncology Society, Association of Academic Surgeons, and Association of Women Surgeons.
She volunteers her time and expertise on behalf of the Melanoma Research Foundation, members of her community in need, STEM programs for girls, and other initiatives. She also is fellowship trained in Physician Wellness and Wellbeing and teaches somatic technique, mindfulness-based stress reduction, meditation, and breathwork. -
Varvara A. Kirchner
Associate Professor of Surgery (Abdominal Transplantation) and, by courtesy, of Pediatrics
BioDr. Kirchner completed her medical school, surgical residency and multi-organ transplant fellowship in adult and pediatric liver, pancreas, kidney transplantation and total pancreatectomy with islet auto-transplantation at the University of Minnesota. She underwent further training in living donor liver transplantation and hepatobiliary surgery at the Asan Medical Center, Seoul, South Korea. Her clinical practice involves living and deceased donor liver and kidney transplantation in adult and pediatric patients as well as total pancreatectomy with islet auto-transplantation for patients with chronic and acute recurrent pancreatitis. She currently serves as Surgical Director of the Islet Cell Auto-Transplant at Stanford Children’s and Associate Director of the Living Donor Liver Transplant Program at the Division of Abdominal Transplantation. Dr. Kirchner’s research focuses on the biology of aging, cellular and solid organ transplantation. Her specific interests are in auto-islet transplantation, iPSC-derived hepatocyte therapies and liver regeneration. Dr. Kirchner's research on the impact of donor age on generation of iPSC-derived hepatocyte-like cells is supported by the NIA K08 Faculty Development Award. She is an active member of the American Society of Transplant Surgeons and the International Liver Transplantation Society.
-
Karla Kirkegaard
Violetta L. Horton Professor and Professor of Microbiology and Immunology
Current Research and Scholarly InterestsThe biochemistry of RNA-dependent RNA polymerase function, the cell biology of the membrane rearrangements induced by positive-strand RNA virus infection of human cells, and the genetics of RNA viruses, which, with their high error rates, live at the brink of error catastrophe, are investigated in the Kirkegaard laboratory.
-
Hannah Louise Kirsch, MD
Clinical Associate Professor, Adult Neurology
BioHannah Louise Kirsch, MD is a board-certified neurologist and a Clinical Assistant Professor in the Neurocritical Care Division of the Department of Neurology & Neurological Sciences at Stanford University School of Medicine.
Dr. Kirsch is also a hospitalist who pays special attention to delivering Stanford Health Care patients the best possible neurological care.
She serves on the National Institute of Neurological Disorders and Stroke committee dedicated to coma and conditions related to consciousness. She has implemented numerous neurology-centered educational activities for health care professionals from diverse specialties, including training psychiatrists on the neuropsychiatric complications of COVID-19. She also has helped educate oncologists and hematologists regarding common neurological conditions among cancer patients.
Dr. Kirsch has conducted research on a range of topics, including thrombotic complications in critically ill COVID-19 patients, advances in intracranial pressure monitoring, and predictors of outcomes in acute encephalitis. She has published her findings in Neurology, the Journal of Trauma, Emergency Medicine, and Procedures, among other journals.
She has given presentations on topics including variations in coagulation among patients with cerebral hemorrhage and the association of cerebral pressure with cardiac arrest. She has shared her discoveries at meetings of the Neurocritical Care Society and Society of Hospital Medicine.
The Neurocritical Care Society has honored her work. She also won the prestigious Leonard Tow Humanism in Medicine Award, which recognizes clinical excellence, outstanding compassion in the delivery of care, and respect for patients, families, and health care colleagues.
Dr. Kirsch received her medical degree from New York University. She completed her residency in neurology at the University of California, San Francisco, and a fellowship in neurocritical care at Columbia University. She also completed the Columbia University narrative medicine certificate program and is board certified in neurology by the American Board of Psychiatry and Neurology. -
Derek M. Klarin, MD
Member, Cardiovascular Institute
BioDr. Klarin is a fellowship-trained vascular surgeon.
For each patient, he develops a comprehensive, compassionate care plan customized to individual needs. His goal is to help each patient achieve the best possible health and quality of life.
Dr. Klarin performs the full spectrum of diagnostic and treatment procedures for cardiovascular conditions. He treats carotid disease, peripheral artery disease, abdominal aortic aneurysm, venous thromboembolism, and other vascular diseases.
To help advance his field, Dr. Klarin has conducted research. The American Heart Association, Howard Hughes Medical Institute, and other organizations have provided grants to support his studies. He also has co-patented advances in predicting and scoring risk factors for cardiovascular disease and other conditions.
He has published extensively and co-authored more than 50 articles on new techniques and technology for diagnosing and treating cardiovascular disorders. His work has appeared in the Journal of Vascular Surgery, Circulation, JAMA, Nature Medicine, and other peer-reviewed journals.
He also has made many invited presentations to his peers. He has spoken at the Vascular Research Initiatives Conference presented by the Society for Vascular Surgery, the American Heart Association Scientific Sessions, and the annual meeting of the American Society for Human Genetics. Topics include risk factors for peripheral artery disease, the benefits of ultrasound screening for abdominal aortic aneurysm, and the impact of genetic variations on cardiovascular disease.
He is a member of the Global Lipids Genetics Consortium. He is a founding member of the Abdominal Aortic Aneurysm Genetics Consortium and the Peripheral Artery Disease Genetics Consortium. He is also a candidate member of the Society for Vascular Surgery. -
Jeffrey Howard Kleck
Adjunct Professor, Rad/Molecular Imaging Program at Stanford
BioDr. Jeff Kleck
Current Roles
Adjunct Professor, Stanford University School of Medicine — Stanford, California
Senior Partner, Eleven of Ten (Elevens) — Menlo Park, California
Chairman, Open Power & Energy Network (OPEN) — Washington, District of Columbia
Senior Advisor, United States Department of War (US DoW) — Pentagon, Arlington, Virginia
Previous Academic Appointments
Dean of Academics, Catholic Institute of Technology (CIT) — Cambridge, Massachusetts & Castel Gandolfo, Italy
Adjunct Associate Professor, University of California, Los Angeles (UCLA)
Visiting Scientist, Lawrence Berkeley National Laboratory (LBNL)
Visiting Scientist, Los Alamos National Laboratory (LANL)
Previous Commercial Technology Ventures
President and Board Member, Rapid AI
Founder, CEO, and Chairman of the Board, Attainia
Founder, CEO, and Chairman of the Board, Neoforma
Previous Government Service
Senior Advisor, United States Department of Defense (US DoD)
Director, Defense Innovation Unit (DIU), United States Department of Defense (US DoD)
Education
Ph.D., Biomedical Physics, University of California, Los Angeles (UCLA)
M.S., Engineering Management, Stanford University, Stanford
M.S., Nuclear Engineering, Texas A&M University, College Station (TAMU)
B.S., Nuclear Engineering, Texas A&M University, College Station (TAMU)
St. John's University, Collegeville (SJU)
The University of Texas, Austin (UT)
Awards in Current Roles
Ukraine Foreign Military Medal, bestowed by the Commander of the Ukraine Armed Forces (2023)
U.S. Department of Defense Award for Team Cyber & IT Excellence, bestowed by the US DoD Chief Information Officer (2019) -
John Kleimeyer, MD
Clinical Assistant Professor, Orthopaedic Surgery
BioDr. Kleimeyer specializes in orthopaedic spine surgery, treating cervical, thoracic and lumbar spine disorders including disc herniations, stenosis, myelopathy, fractures, scoliosis and more. He treats both simple and complex spine problems including revisions. His goal is to provide the most minimally invasive solution to improve patients’ quality of life. This includes less invasive discectomies, decompressions, disc replacements, and fusions. He is particularly focused on single-position procedures to limit surgical time and recovery.
Prior to coming to the Stanford Department of Orthopaedic Surgery and the Stanford Spine Center, Dr. Kleimeyer completed his residency in orthopaedic surgery at Stanford University where he was elected to the Alpha Omega Alpha honor society. He then completed his spine fellowship at the renowned Emory University Spine Center. He is board-certified.
Dr. Kleimeyer has received honors and recognition for his research in the fields of orthopaedic surgery and spine surgery. He participates in national and international specialty societies and as a journal reviewer. His research interests include improving clinical outcomes of surgical and nonsurgical care, the genetics of orthopaedic and spine disorders, and cost efficacy. Dr. Kleimeyer has published over 20 journal articles in addition to other reviews and textbook chapters, and has presented research nationally and internationally. -
Clarissa Klein
Scientific Data Curator 2, Biomedical Data Science
BioScientific curator and coordinator for the Clinical Genome Resource (ClinGen) and the Pharmacogenomics Knowledgebase (PharmGKB) / ClinPGx. Program Manager for Stanford ClinGen.
Coordinator for ClinGen's Data Access, Protection, and Confidentiality (DAPC) Working Group, the Rheumatologic and Autoimmune Diseases Clinical Domain Working Group (RAD-CDWG), Multigenic Taskforce, HLA Working Group, and the Pharmacogenomics Working Group (PGxWG). Coordinator for PharmGKB's submission for FDA recognition of their clinical annotation database, and curator with a focus on PharmGKB Pediatric. -
Jonathan D Klein
Marron and Mary Elizabeth Kendrick Professor of Pediatrics
Current Research and Scholarly InterestsMy studies address:
1. Confidentiality and Access to Care studies of confidential time during well-visits and policy analyses addressing quality of care and health systems capacity for adolescents and young adults in the US and globally; and,
2, Tobacco, nicotine, and second-hand smoke studies of primary care counseling to reduce nicotine addiction in adolescents and programs to engage medical specialty groups in secondhand smoke clinical and policy interventions. -
Teri Klein
Professor (Research) of Biomedical Data Science, of Medicine (Computational Medicine) and, by courtesy, of Genetics
Current Research and Scholarly InterestsCo-founder, Pacific Symposium on Biocomputing
NIEHS, Site Visit Reviewer
NIH, Study Section Reviewer -
Nathan Kline
Adolescent Screenomics Study Coordinator, Peds/Disease Prevention
Current Role at StanfordAs the Adolescent Screenomics Study Coordinator, I have collaborated with Dr. Tom Robinson and the rest of the Stanford Solutions Lab team to create the groundwork for the Adolescent Screenomics study. Some of this groundwork includes: developing and maintaining a RedCap project with over 20 instruments and over 800 notifications with branching logic. I also have been collaborating with programmers and RedCap administrators to manage compensation related to smartphone use, create a zoom scheduler to onboard adolescent participants, and automate the distribution of gift cards. Moreover, I have been developing and maintaining our study website. Finally, I have been developing advertisements on Facebook, Instagram, etc. to advertise for our study. Once our study is approved by the IRB officially, I will begin recruiting and onboarding adolescent participants, obtaining informed consent (from their parents/guardians) and assent, and monitoring completion of the study.
-
Samantha M.R. Kling
Quantitative Research Scientist, Medicine - Primary Care and Population Health
Current Role at StanfordQuantitative Research Scientist in the Evaluation Sciences Unit (ESU)
-
Hanna Maria Knihtila
Affiliate, Department Funds
Fellow in Pediatrics - Allergy and Clinical ImmunologyBioHanna Knihtilä is an Allergy and Immunology Fellow at Stanford. She gained her MD in 2017 and PhD in 2018 from the University of Helsinki, Finland. She then completed her 2-year postdoctoral research fellowship at the Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, before joining Stanford for her residency and fellowship training.
-
Joshua W. Knowles
Associate Professor of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsGenetic basis of coronary disease
Genetic basis of insulin resistance
Familial Hypercholesterolemia (FH) -
Juliet Klasing Knowles
Assistant Professor of Neurology and Neurological Sciences (Pediatric Neurology) and of Pediatrics
Current Research and Scholarly InterestsThe Knowles lab studies how white matter structure changes in different forms of epilepsy, and how aberrant white matter structure, in turn, shapes neuronal network function. In mouse models, we use a variety of innovative tools including neurophysiology, quantitative EEG, behavior, histological measures of white matter structure and MR imaging. We also conduct clinical research to study white matter abnormalities in children with epilepsy.
-
Lisa Marie Knowlton, MD, MPH, FACS, FRCSC
Associate Professor of Surgery (General Surgery)
BioDr. Knowlton is an Associate Professor of Surgery and an Acute Care Surgeon whose practice encompasses trauma surgery, emergency general surgery and surgical critical care. She is an NIH and ARPA-H funded researcher whose focus is on improving access to innovative, high-quality surgical care. She obtained her medical degree at McGill University and completed her general surgery residency at the University of British Columbia in Vancouver, Canada. Her desire to understand varied healthcare systems and develop policy solutions led her to obtain an M.P.H. at the Harvard T.H. Chan School of Public Health and complete a research fellowship at the Harvard Humanitarian Initiative. After training as a Surgical Critical Care fellow at Stanford University Medical Center, she joined the faculty as an Assistant Professor of Surgery in early 2018. She was promoted to Associate Professor in the University Medical Line in 2023. Her institutional leadership roles include serving as the Unit Based Medical Director of the Surgical Intensive Care Unit, the Associate Vice Chair of Research for the Stanford Department of Surgery, the SHC Surgical AI Lead for Early Clinical Deterioration, and the Associate Program Director for the Surgical Critical Care fellowship.
Dr. Knowlton is board certified by the American Board of Surgery and the Royal College of Physicians and Surgeons of Canada. Dr. Knowlton’s areas of clinical interest include developing safe surgical solutions for anatomic visualization in the operating room, artificial intelligence prediction tools for detection early clinical deterioration of surgery patients, optimizing the management of critically ill patients and reducing venous thromboembolism events.
Her research focuses on improving access to high-quality and high-value surgical care, merging expertise in health economics, and artificial intelligence to implement surgical innovations and health policy interventions. She leads novel work with the Department of Health Care Services focused on improving healthcare access and utilization through emergency Medicaid programs.
Dr. Knowlton’s research lab (https://med.stanford.edu/knowlton-lab.html) is funded by the Advanced Research Projects Agency for Health (ARPA-H), the National Institute of Health (NIMHD) through R21 and R01 grants, and the California Violence Prevention Center. She has also held funding through PCORI, the Department of Defense, the American College of Surgeons (the 17th C. James Carrico Faculty Research Fellowship), and the American Association for the Surgery of Trauma (AAST).
https://surgery.stanford.edu/news2/Knowlton-ARPA-H.html
She is active in national and international professional surgical societies, and recently served as the inaugural Chair of the Associate Member Council of the AAST. Dr. Knowlton has been recognized by the Association of Women Surgeons as both a ‘Shining Star’ and ‘Breaking the Glass Ceiling’ Leadership Scholar. She is also an American College of Surgeons Health Policy Scholar. Most recently, Dr. Knowlton was also selected as the 2023-24 U.S. ambassador for the James IV Surgical Association Traveling Fellowship program, where she will travel internationally to foster clinical and research collaborations. -
Susan Knox
Associate Professor of Radiation Oncology, Emerita
Current Research and Scholarly InterestsOur interests include 1) study of the effect of radiation on regulatory cell subpopulations and co-stimulatory molecules, 2) use of radiation as an immune modulator for optimization of transplant regimens, 3) the role of radiation in tumor vaccine strategies, 4) study of new radiosensitizers and radioprotectors, and 5) discovery of new targeted therapies for the treatment of solid tumors.
-
Eric I. Knudsen
Edward C. and Amy H. Sewall Professor in the School of Medicine, Emeritus
Current Research and Scholarly InterestsCellular mechanisms of spatial attention and learning, studied in the central nervous system in birds, using behavioral, systems, cellular and molecular techniques.
-
Justin M Ko, MD, MBA
Clinical Professor, Dermatology
BioJustin Ko joined Stanford Medicine in 2012. He is a Clinical Professor and Associate Chair of Clinical Affairs in the Department of Dermatology and Chief of Dermatology at Stanford Healthcare where he spearheads the dermatology department's clinical enterprise including efforts around digital health, network development, quality and value-based care. He also holds health system leadership roles within Stanford Medicine including as Associate Chief Quality Officer and physician lead of Patient Experience and Ambulatory Access. Justin is a clinical expert in skin cancer and melanoma as well as alopecia areata and hair loss disorders, and is a leader and researcher in the areas of care delivery innovation and Artificial/Augmented Intelligence.
His passion for melanoma, early cancer detection, and improving care delivery drives his efforts and research around leveraging advances in machine learning and artificial intelligence to increase the breadth of populations that can be reached. He developed and runs a digital care delivery program at SHC, providing virtual visits for patients and remote consultations for referring clinicians. He conducts research on and engages in collaborations around interventions that layer advances in machine learning on digital health capabilities to enhance access, quality and value of dermatologic care and is a co-founder and co-leader of the Stanford Translational AI in Dermatology (TRAIND) group. He co-founded and chaired the American Academy of Dermatology's (AAD) Committee on Augmented Intelligence and has served as chair of the AAD's Health Information Technology Committee.
Dr. Ko has also been driven to find new treatments for alopecia areata, an immune-mediated condition that can progress to total hair loss through various clinical trials and translational research efforts. He sits on the clinical research advisory board of the National Alopecia Areata Foundation and is a co-founder of the Skin Innovation and Interventional Research Group (SIIRG) which conducts clinical and translational research on skin disease.
He graduated magna cum laude from Harvard University and worked in investment banking; mergers and acquisitions at JP Morgan before going on to earn a combined medical and business degree at Tufts University. During medical school, he was a member of the Alpha Omega Alpha honor society. Dr. Ko then performed his residency at the Harvard Dermatology Residency Training Program where he served as chief resident.
